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Abstract
Human cytomegalovirus (HCMV) is the largest human herpesvirus and its virion contains many viral encoded proteins found
in the capsid, tegument, and envelope. In this study, we carried out a yeast two-hybrid (YTH) analysis to study potential
binary interactions among 56 HCMV-encoded virion proteins. We have tested more than 3,500 pairwise combinations for
binary interactions in the YTH analysis, and identified 79 potential interactions that involve 37 proteins. Forty five of the 79
interactions were also identified in human cells expressing the viral proteins by co-immunoprecipitation (co-IP) experiments.
To our knowledge, 58 of the 79 interactions revealed by YTH analysis, including those 24 that were also identified in co-IP
experiments, have not been reported before. Novel potential interactions were found between viral capsid proteins and
tegument proteins, between tegument proteins, between tegument proteins and envelope proteins, and between
envelope proteins. Furthermore, both the YTH and co-IP experiments have identified 9, 7, and 5 interactions that were
involved with UL25, UL24, and UL89, respectively, suggesting that these ‘‘hub’’ proteins may function as the organizing
centers for connecting multiple virion proteins in the mature virion and for recruiting other virion proteins during virion
maturation and assembly. Our study provides a framework to study potential interactions between HCMV proteins and
investigate the roles of protein-protein interactions in HCMV virion formation or maturation process.
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Introduction
Human cytomegalovirus (HCMV) is a member of the human
herpesvirus family, which includes herpes simplex virus 1 (HSV-1),
Varicella-zoster virus (VZV), Epstein-Barr virus (EBV), and
Kaposi’s sarcoma-associated herpesvirus (KSHV) [1]. This virus
is an important opportunistic pathogen affecting individuals whose
immune functions are compromised or immature [1,2]. For
example, HCMV is a leading cause of retinitis-associated blindness
and other debilitating conditions such as pneumonia and enteritis
among AIDS patients [3,4]. Moreover, this virus causes mental
and behavioral dysfunctions in children that have been infected in
utero [1,2]. Understanding the mechanism of how HCMV
replicates and how viral proteins interact is critical in developing
new compounds and novel strategies to control HCMV infections
and prevent HCMV-associated diseases.
HCMV is the largest human herpesvirus, which encodes more
than 150 open reading frames (ORFs) [5,6,7]. Its virion structure
is also the largest and most complicated among human
herpesviruses [8,9]. Like other herpesviruses, HCMV virion is
composed of an icosahedral capsid that contains a linear double-
stranded DNA genome with attached proteins and an outer layer
of proteins termed the tegument, surrounded by a viral envelope,
which is derived from the cellular lipid bilayer and contains viral
envelope glycoproteins [10,11]. The capsid, which is exclusively
assembled in the nucleus, contains five viral proteins encoded by
open reading frame (ORF) UL86 (major capsid protein (MCP)),
UL85 (minor capsid protein), UL80 (capsid assembly protein),
UL48.5 (small capsid protein), and UL46 (minor capsid protein
binding protein) [10,11]. UL86 is the most abundant capsid
protein and, together with UL85, UL48.5, and UL46, is present
on the surface. The capsid is surrounded by the tegument, which
is acquired in both the nucleus and cytoplasm of the infected
cells. Mass spectrometry analysis of HCMV infectious particles
indicated that more than 30 HCMV proteins of at least 100
amino acids, including UL24, UL25, UL26, UL32, UL43, UL47,
UL48, UL82, UL83, UL94, UL99, US22, US23, US24, UL44,
UL45, UL54, UL57, UL69, UL72, UL84, UL89, UL97, UL122,
UL35, UL51, UL71, UL79, UL88, UL96, UL103, UL104, and
UL112, were found in the tegument compartment [12,13].
Quantitative proteomic analysis of HCMV virions suggested that
the amounts of these proteins varied, with UL83 and UL99 as the
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15.4% and less than 0.1% of the total virion mass, respectively
[12].
During virion maturation, nucleocapsids bud through nuclear
membranes by acquiring a part of tegument and envelope.
Subsequently, the cytoplasmic viral capsids containing tegument
are enveloped further by budding into the trans-Golgi network or
a closely apposed cellular compartment. More than 15 virally
encoded envelope proteins, including RL10, UL5, UL22A (also
called UL21.5), UL33, UL38, UL41A, UL50, UL55, UL73,
UL74, UL75, UL77, UL93, UL100, UL115, UL119, UL132, and
US27, have been found in the virion [12,13].
The structure of the HCMV capsid has been studied by cryo-
electron microscopy (cryo-EM) [8,9] and recently refined to a
resolution of 12.5 A [14]. In addition, interactions between capsid
proteins have been investigated by yeast (Saccharomyces cerevisiae)
two-hybrid (YTH) analysis as well as numerous biochemical and
genetic approaches [14,15,16,17,18,19,20]. In contrast, the
structure of the HCMV tegument is largely unknown. By cryo-
EM, an icosahedrally ordered tegument density was visualized in
HCMV particles when compared to precursor capsids prior to
DNA encapsidation [8,9]. However, the identity of the protein
components of the tegument density has not been clearly
determined. Moreover, the orientation and interaction of HCMV
proteins in the virion have not been extensively studied.
Much of what is currently known about the interactions among
herpesvirus capsid and tegument proteins come from various studies
involving protein assays and in particular, YTH analyses
[20,21,22,23,24]. Large-scale YTH analyses [25] have also been
applied to interactome studies of many organisms such as Homo sapiens,
Drosophila melanogaster, Caenorhabditis elegans, Saccharomyces cerevisiae,
Plasmodium falciparum,a n dHelicobacter pylori [26,27,28,29,30]. In
complex organisms where their genome sizes are relatively large, it is
difficult to assess the importance of each individual protein to the
systems. Therefore, it is important to map the global interactome to
assess the true significance of each protein. Global genetic YTH
analysis was also used to study the interactions between proteins
encoded by vaccinia virus [31] and five herpesviruses, which include
herpes simplex virus 1 (HSV-1), Varicella-zoster virus (VZV), Epstein-
Barr virus (EBV), murine cytomegalovirus (MCMV), and Kaposi’s
sarcoma-associated herpesvirus (KSHV) [21,22,23,24]. Furthermore,
the potential interactions among 5 capsid proteins and 28 tegument
proteins of HCMV have recently been investigated using the YTH
approach [20]. These results have provided significant insights into the
interactions among proteins encoded by herpesviruses.
In this study, we have carried out a comprehensive YTH
analysis to identify potential interactions among 56 HCMV virion
proteins, which include 5 capsid proteins, 33 tegument proteins,
and 18 envelope proteins. We have identified 79 pairs of potential
interactions that are involved in viral capsid proteins, tegument
proteins, and envelope proteins. Of the 79 interactions, 58 have
not been previously identified to the best of our knowledge, while
21 of them have been reported. Forty-five of these 79 putative
interactions were also identified in human cells by co-immuno-
precipitation (co-IP) experiments. Our results indicate the presence
of several HCMV proteins that serve as ‘‘hubs’’ for interactions
with numerous protein partners, thereby may function as an
organizing center for connecting viral proteins in the mature
virion and for recruiting other virion proteins. The interactions
identified in this study provide a framework to study potential
interactions between HCMV proteins and to investigate the
functional roles of protein-protein interactions in HCMV virion
assembly.
Results
Cloning of HCMV ORFs for yeast two-hybrid analysis
We have previously determined the genomic sequence of a
HCMV Towne strain that was cloned into a bacterial artificial
chromosome (BAC) vector [32] and was maintained as a single
copy BAC-based plasmid in E.coli [7]. When introduced into
human cells, the viral DNA sequence of this construct, TowneBAC,
produces infectious progeny and retains wild type growth
characteristic in vitro. These results suggested that the genome
sequence of TowneBAC encodes a collection of functional viral
genes responsible for viral replication and infection [7,33].
We then used the locally written Unix-based scripts or
automation of GCG package to analyze the obtained TowneBAC
sequence and determine the coding sequences for ORFs that are
100 codons or longer. Each ORF was compared with the set of
ORFs that had been predicted or found in all the HCMV strains
for which sequences have been determined [5,6,7,33,34,35]. This
analysis suggested that the TowneBAC sequence encodes at least
150 ORFs with 100 amino acids or longer, and that all these
ORFs align with those found in other HCMV strains [7] (data not
shown).
To study potential interactions among HCMV-encoded pro-
teins in viral infectious particles, we cloned and expressed, in the
yeast-two hybrid system, 56 HCMV ORFs that encode proteins
that have been identified as virion components by mass
spectrometry [12,13]. Those cloned and expressed ORFs include
5 capsid proteins (UL46, UL48.5, UL80, UL85, and UL86), 33
tegument proteins (UL24, UL25, UL26, UL32, UL43, UL47,
UL48 cloned individually as N9 and C9-terminal truncated
fragments, UL82, UL83, UL94, UL99, US22, US23, US24,
UL44, UL45, UL54, UL57, UL69, UL72, UL84, UL89 exon 1
(UL89.1)/UL89 exon 2 (UL89.2), UL97, UL122, UL35, UL51,
UL71, UL79, UL88, UL96, UL103, UL104, and UL112 exon 1
(UL112.1)/exon 2 (UL112.2)), and 18 envelope proteins (RL10,
UL5, UL22A (also called UL21.5), UL33, UL38, UL41A, UL50,
UL55, UL73, UL74, UL75, UL77, UL93, UL100, UL115,
UL119, UL132, US27).
We initially selected an optimal PCR primer pair for each ORF
(Supporting Information Table S1). The primer pairs used for
amplification of the viral sequences were constructed as follows.
The forward primer contained (from 59 to 39) the sequence
immediately after the predicted translation initiation codon and
20–25 additional nucleotides of coding sequence. The reverse
primer contained the reverse complement of both the predicted
translation termination codon and the preceding 20–25 nucleo-
tides at the end of the ORF (Supporting Information Table S1). In
addition, these primers also contain 15–20 nucleotide common
sequences that contain sites for restriction enzymes for cloning of
the PCR products into the YTH screen vectors (pGADT7 and
pGBKT7) and the mammalian expression vectors (pCMV-HA
and pCMV-Myc) (Supporting Information Table S1).
Each ORF encoding HCMV virion proteins was amplified
individually by PCR. The amplified PCR products covered the
entire ORFs minus the translation initiation codon (Figure 1), and
were cloned into both the yeast two-hybrid screen ‘‘prey’’
pGADT7 and ‘‘bait’’ pGBKT7 vectors. We generated a collection
of 118 constructs that contained the sequences of the 56 HCMV
ORFs, including those coding for exons 1 and 2 of UL89, the
amino and carboxyl domains of UL48, and exons 1 and 2 of
UL112 (Figure 1, Supporting Information Table S2). The viral
ORF sequences in these constructs were confirmed using DNA
sequencing analysis (data not shown).
HCMV Virion Protein Interactions
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encoded virion proteins using YTH analysis
Our strategy was to test each pair-wise combination of HCMV-
encoded virion proteins in the YTH assay using a 48-well protein
array format. The array consisted of a set of yeast transformants,
each expressing a HCMV ORF as a hybrid protein with the Gal4
DNA binding domain (BD). This array was mated to yeast
transformants of the opposite mating type carrying one of the
HCMV ORFs as a hybrid protein with the Gal4 activation
domain (AD). The resulting diploids were cultured on the medium
selective for the two-hybrid reporter genes. In this approach, a
single protein could be tested for binary interaction with the
protein encoded by every cloned HCMV ORF in the array. By
generating a different set of activation and DNA binding domain
Figure 1. HCMV ORF sequences generated by PCR and cloned in yeast and mammalian expression vectors. (A) The PCR products for
the HCMV ORFs separated on 1% agarose gels. (B) The predicted sizes of the PCR products for the HCMV ORFs based on the PCR primers used.
doi:10.1371/journal.pone.0017796.g001
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mating and selection experiments to assay all of the ,3500
combinations (Figure 2, Supporting Information Table S2).
To generate the yeast transformants for YTH analysis, DNAs
from each of the 59 generated ‘‘bait’’ pGBKT7-derived constructs
were isolated from E.coli, and transformed into yeast strain
AH109, resulting in a collection of different yeast transformants
that expressed a set of 59 DNA-binding domain (BD) hybrid
proteins (Supporting Information Table S2). Similarly, DNAs
from the generated ‘‘prey’’ pGADT7-derived constructs were
isolated and transformed into yeast strain Y187 to generate yeast
transformants expressing a set of 59 activation domain (AD)
hybrid proteins.
Prior to performing mating experiments, all 59 pGBKT7-fusion
proteins in AH109 strains were tested for autoactivation. Seven
AH109 strains, which contained ORFs UL48.5, UL26, UL48N,
UL48C, UL94, US23, and UL51, were determined to be
autoactivators in the absence of any pGADT7-cloned ORFs
(Table 1), and subsequently eliminated from any further mating
experiments. Each of the remaining 52 AH109 strains was allowed
to mate with each of the 59 constructed Y187 strains in duplicate,
and the diploid cells were plated in duplicate on selective medium.
Besides selecting for the presence of the two plasmids based on
leucine and tryptophan selection, we employed a high stringency
selection of positive protein interactions by using 3 more reporter
genes to eliminate potential false positives: histidine, adenine, and
Mel1, which encodes alpha-galactosidase for blue/white screen-
ing. The growth of colonies of the diploid yeast cells with a blue
staining within 3 weeks after plating was scored as a positive pair-
wise interaction between the two proteins tested while other results
(e.g. no growth of yeast colonies) were scored as a negative
interaction (Figure 2, Supporting Information Table S2). There
was no significant difference in the growth of the diploid yeast cells
representing all the positive interactions (data not shown).
Two-hybrid screens may generate a significant number of false
positives that represent random generation of histidine-positive
colonies. This is possibly due to rearrangement and deletion of the
DNA-binding domain plasmids, recombinational events between
the DNA-binding and activation domain plasmids, or genomic
rearrangement of the host strain. To exclude these possibilities,
three sets of experiments were carried out. First, plasmid DNAs
from the yeast transformants were recovered and analyzed. Our
results indicated that these constructs were present in all
transformants examined and exhibited similar restriction enzyme
profiles as those in E. coli. Second, all screens were carried out in
duplicate to determine whether the results were reproducible.
Third, any protein that resulted in histidine-positive growth with
the empty vector controls (i.e. pGADT7 and pGBKT7) was
classified as a false positive.
The .3000 combination screen of the mating of 52 HCMV
Gal4 DNA-binding and 59 HCMV Gal4 activation domain fusion
proteins revealed 79 positive interactions among 37 virion proteins
(Supporting Information Table S2 and Figure 3). We identified 4
interactions between capsid proteins, 2 interactions between
capsid proteins and tegument proteins, 58 interactions between
tegument proteins, 12 interactions between tegument proteins and
envelope proteins, and 3 interactions between envelope proteins
(Table 1 and 2). The 37 participating proteins include all 5 capsid
proteins (UL46, UL48.5, UL80, UL85, and UL86), 27 tegument
proteins (UL24, UL25, UL26, UL32, UL43, UL47, UL48N/
UL48C, UL82, UL83, UL94, UL99, US22, US23, US24, UL44,
UL45, UL54, UL69, UL72, UL89.2, UL122, UL35, UL51,
UL71, UL88, UL103, UL112.1), and 5 envelope proteins
(UL22A, UL38, UL50, UL77, UL132). Of these 79 identified
interactions, 58 are novel (Table 2) while the other 21 have
previously been reported (Table 1).
Twelve proteins, which include 2 capsid proteins (UL80 and
UL85), 9 tegument proteins (UL24, UL25, UL82, UL69, UL89,
UL122, UL71, UL103, and UL112), and 1 envelope protein
(UL77), were found to be self-interacting. Previous analyses have
shown the self-interaction of UL80, UL85, UL25, UL69, and
UL112 [10,15,20,36]. These results suggest that all 12 proteins
may form dimers or self-assemble into polymers. These notions are
consistent with previous observations that UL85 is the minor
capsid protein that can self-assemble into pre-caspid particles and
that UL80 self-interacts and forms a dimer (Table 1) [10,15].
Of the 79 interactions identified, 11 of them were reciprocal
interactions that were tested and confirmed in both orientations in
the YTH assay (Supporting Information Table S2, Figures 2–3),
strongly supporting the validity of these interactions. Excluding the
12 self-interactions and 11 reciprocal interactions, the remaining
56 interactions were detected in only one direction. Interactions
Figure 2. Protein-protein interactions between HCMV ORFs as identified by YTH analysis. In (A–B), a directional interaction is shown with
the interaction existing only in BDUL86-ADUL48.5 (B) but not in BDUL48.5-ADUL86 (A). Interactions detected only in one direction are common in
YTH assays and are most likely due to steric hindrance of either bait or prey fusion proteins [21,22,23]. In (C–D), an example of reciprocal interactions
is shown with BDUL24-ADUL69 and the reverse combination. In (E–F), BDUL-Lam and BDUL-p53 are the human lamin C and murine p53 proteins
fused to the BD domain of GAL4, respectively, while ADUL-T is the SV40 large T-antigen fused to the AD domain of GAL4. Murine p53 and SV40 T-
antigen interact and serve as a positive control (F) while human lamin C and SV40 T-antigen do not interact and serve as a negative control (E).
Diploids were plated on SD/-Leu/-Trp/-Ade/-His/X-a-Gal agar plates to test for protein-protein interactions. Positive interactions had blue yeast
colony growth (B, C, D, and F), whereas no interactions were shown by the absence of growth (A and E). We observed similar growth of the diploid
yeast cells representing the positive interactions.
doi:10.1371/journal.pone.0017796.g002
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most likely are due to steric hindrance of either bait or prey fusion
proteins [21,22]. Among these 79 interactions, 18 were found to
be involved with UL24 while 11 and 10 were with UL25 and
UL89.2, respectively (Figure 3, Table 1 and 2). These results raise
the possibility that these proteins may function as a hub or
organizing center for connecting viral proteins in the mature
virion and for recruiting other virion proteins during virion
maturation and assembly. UL24, the only tegument protein
identified in this study to interact with a capsid protein (e.g. UL46),
may be especially important in this process.
Expression of HCMV virion proteins and investigation of
their interactions in human cells
A co-immunoprecipitation (co-IP) assay was employed to
validate the yeast two-hybrid approach and to determine whether
the identified interactions occur in human cells. Figure 4 shows the
results of the co-IP experiments that examined six of the
interactions identified in the YTH analysis, UL24-UL25, UL69-
UL69, UL82-UL94, UL83-UL25, UL99-UL94 and its reciprocal,
UL94-UL99 (lanes 1–6). Two pair interactions, UL99-UL83 and
UL25-UL94, which showed no interactions in our YTH screen,
were also included as control experiments (lanes 7 and 8). In these
experiments, the HCMV ORFs were cloned into mammalian
expression vectors pCMV-Myc and pCMV-HA, in which each
ORF was expressed as either a fusion protein with a carboxyl
terminal c-myc or HA epitope tag, respectively. HeLa and
U373MG cells were transfected with the mammalian expression
constructs and were harvested at 72 hours. To detect the
expression of these proteins, transfected cells were lysed and
proteins were separated electrophoretically on SDS-containing
gels, transferred electrically to membranes, and reacted with anti-
HA and anti-c-myc antibodies. UL24, UL25, UL69, UL82, UL83,
UL94 and UL99 were detected as proteins of about 40, 80, 90, 70,
Table 1. Protein-protein interactions of HCMV virion proteins that have either been previously reported or suggested, and were
positive in our YTH and co-IP analysis.
BD ORFs and Function AD ORFs and Function Co-IP
Reported in
HCMV Reported in other Herpesviruses References
Capsid Protein-Capsid Protein Interactions
UL46 Minor capsid protein binding
protein (E)
UL85 Minor capsid protein (E) + UL46-UL85 UL38-UL18 (HSV-1) [10,41]
UL80 Protease/Capsid assembly
precursor (E)
UL80 Protease/Capsid assembly
precursor (E)
+ UL80.5-UL80.5 UL26.5-UL26.5 (HSV-1);
Orf33-Orf33 (VZV)
[17,18,22,41]
UL85 Minor capsid protein (E) UL85 Minor capsid protein (E) + UL85-UL85 [15,16]
UL86 Major capsid protein (E) UL48.5 Smallest capsid protein (E) + UL86-UL48/49 [19]
Tegument Protein-Tegument Protein Interactions
UL25 Tegument protein (NE) UL25 Tegument protein (NE) + UL25-UL25 [20]
UL25 Tegument protein (NE) UL26 Transcription (D) + UL25-UL26 [20]
UL32 Basic phosphoprotein (E) UL35 Tegument (Transcription)
(D)
+ UL32-UL35 [20]
UL32* Basic phosphoprotein (E) UL82 Transcription (D) + UL32-UL82 [20]
UL35* Transcription (D) UL82 Transcription (D) + UL35-UL82 [45]
UL43* Tegument protein (NE) UL83 Tegument
(immunomodulation) (NE)
+ UL43-UL83 [20]
UL45 Ribonucleotide reductase
homologue (NE)
UL25 Tegument protein (NE) + UL45-UL25 [20]
UL45 Ribonucleotide reductase
homologue (NE)
UL69 Transcription (D) + UL45-UL69 Orf61-Orf57 (KSHV) [22]
UL47 Tegument protein (D) UL48N Tegument protein (E) + UL37-UL36 (PRV), Orf63-Orf64 (KSHV) [22,24]
UL69 Transcription (D) UL69 Transcription (D) + UL69-UL69 Orf57-Orf57 (KSHV) [22,36]
UL72 Unknown function (D) UL89.2 DNA packaging/cleavage
(E)
+ Orf54-Orf29b (KSHV) [22,24]
UL82 Transcription (D) UL82 Transcription (D) + Orf16-Orf16 (VZV) [22,24]
UL82 Transcription (D) UL94 Tegument protein (E) + UL82-UL94 [20]
UL88 Unknown function (D) UL48N Tegument protein (E) + UL88-UL48 [20]
UL99 Envelopment (E) UL94 Tegument Protein (E) + UL99-UL94 UL11-UL16 (HSV-1) [38]
UL112.1 Early protein (D) UL112.1 Early protein (D) + UL112-UL112 [39]
Envelope Protein-Envelope Protein Interactions
UL77 DNA packaging/cleavage (E) UL77 DNA packaging/cleavage
(E)
+ Orf34-Orf34 (VZV) [22,24]
Interactions marked by an asterisk represent reciprocal interactions. ‘‘+’’ represents positive interactions identified by co-IP experiments in human cells (co-IP). The ORFs
in which deletion results in no viral growth, wildtype-like growth, and significant growth defect in foreskin fibroblasts are marked as ‘‘E’’ (essential), ‘‘NE’’ (non-essential),
and ‘‘D’’ (defect) [7].
doi:10.1371/journal.pone.0017796.t001
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consistent with their coding sequences of 358, 656, 743, 559, 561,
345, and 190 amino acids, as predicted from the HCMV
TowneBAC sequence [7]. The protein species, which migrated at
approximately 82 kDa and was detected by the anti-HA antibody
in the input protein samples of the cell lysate (Figure 4A) but not in
the protein samples immunoprecipitated with either the anti-HA
or anti-myc antibodies (Figure 4C and E), may represent a cellular
protein that non-specifically reacts with the anti-HA antibody.
The six interactions revealed by our YTH analysis appeared to
be identified in the co-IP experiments (Figure 4, lanes 1–6). As an
example, to determine whether UL25 and UL94 interact with
UL83 and UL99 respectively, protein lysates from the transfected
cells were either first immunoprecipitated with anti-HA or anti-c-
myc, and then immunoblotted with antibodies against the c-myc
and HA epitope tags. The HA-tagged UL25 was co-precipitated
with the myc-tagged UL83 (Figure 4C–F, lane 5 and 13), while the
HA-tagged UL99 was found to be associated with the myc-tagged
UL94 and vice versa (lane 3–4 and 11–12). In contrast, we
observed, in control experiments, neither significant binding
between the HA-tagged UL99 and the myc-tagged UL83 (lane
7) nor between the HA-tagged UL25 and the myc-tagged UL94
(lane 8). These results confirm the specificity of the co-IP assay and
suggest that the UL25-UL83 and UL99-UL94 interactions may
occur in human cells. These results are consistent with recent
report of interactions between UL69-UL69, UL82-UL94, and
UL99-UL94 revealed by YTH and co-IP analysis [20]. Similar co-
IP experiments were carried out to study each of the 79 putative
interactions identified in the YTH screens in human cells. Forty
five of these interactions were positive in our experiments while 34
were negative (Table 1 and 2).
Discussion
Large-scale YTH analyses have been applied to interactome
studies of many organisms, including Homo sapiens, Drosophila
melanogaster, Caenorhabditis elegans, Saccharomyces cerevisiae, Plasmodium
falciparum, and Helicobacter pylori [26,27,28,29,30]. Global YTH
 
 
 
 
Figure 3. Interaction map of potential interactions between HCMV virion proteins as revealed by YTH analysis. The shaded hexagon
represents the capsid and the shaded sphere represents the viral particle. The nodes (in yellow) within the capsid represent capsid proteins. The
circular nodes in blue represent tegument proteins. The rectangular nodes in orange represent viral envelope proteins. The green lines represent
interactions identified in one direction only and the red lines represent reciprocal interactions. The solid lines represent the interactions that were
positive in both the YTH analysis and co-IP experiments, while the dashed lines represent the putative interactions that were positive only in the YTH
analysis. The ORFs in which deletion resulted in no viral growth, wildtype-like growth, and significant growth defect in human foreskin fibroblasts are
marked as ‘‘E’’ (essential), ‘‘NE’’ (non-essential), and ‘‘D’’ [7].
doi:10.1371/journal.pone.0017796.g003
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determined by our YTH and co-IP analysis.
BD ORFs and Function AD ORFs and Function Co-IP
Capsid Protein-Tegument Protein Interactions
UL24* Tegument protein (NE) UL46 Minor capsid protein binding protein (E) +
UL24 Tegument protein (NE) UL85 Minor capsid protein (E) +
Tegument Protein-Tegument Protein Interactions
UL24 Tegument protein (NE) UL24 Tegument protein (NE) 2 (putative)
UL24* Tegument protein (NE) UL25 Tegument protein (NE) +
UL24 Tegument protein (NE) UL26 Transcription (D) 2 (putative)
UL24* Tegument protein (NE) UL32 Basic phosphoprotein (E) +
UL24* Tegument protein (NE) UL43 Tegument protein (NE) +
UL24 Tegument protein (NE) UL51 DNA packaging/cleavage (E) 2 (putative)
UL24* Tegument protein (NE) UL69 Transcription (D) +
UL24* Tegument protein (NE) UL71 Unknown function (E) +
UL24 Tegument protein (NE) UL88 Unknown function (D) 2 (putative)
UL24 Tegument protein (NE) UL89.2 DNA packaging/cleavage (E) +
UL24 Tegument protein (NE) US22 Tegument protein (NE) 2 (putative)
UL24 Tegument protein (NE) US23 Tegument protein (D) 2 (putative)
UL25* Tegument protein (NE) UL43 Tegument protein (NE) +
UL25 Tegument protein (NE) UL89.2 DNA packaging/cleavage (E) +
UL32 Basic phosphoprotein (E) UL89.2 DNA packaging/cleavage (E) 2 (putative)
UL43 Tegument protein (NE) UL89.2 DNA packaging/cleavage +
UL44 DNA polymerase accessory protein (E) UL25 Tegument protein (NE) +
UL45 Ribonucleotide reductase homologue (NE) UL24 Tegument protein (NE) 2 (putative)
UL45 Ribonucleotide reductase homologue (NE) UL26 Transcription (D) +
UL45 Ribonucleotide reductase homologue (NE) UL89.2 DNA packaging/cleavage (E) 2 (putative)
UL45 Ribonucleotide reductase homologue (NE) US23 Tegument protein (D) 2 (putative)
UL54 DNA polymerase catalytic subunit (E) UL24 Tegument protein (NE) 2 (putative)
UL54 DNA polymerase catalytic subunit (E) UL26 Transcription (D) 2 (putative)
UL54 DNA polymerase catalytic subunit (E) UL89.2 DNA packaging/cleavage (E) 2 (putative)
UL69 Transcription (D) UL25 Tegument protein (NE) 2 (putative)
UL69 Transcription (D) UL48N Tegument protein (E) +
UL69 Transcription (D) UL89.2 DNA packaging/cleavage (E) 2 (putative)
UL71 Unknown function (E) UL26 Transcription (D) 2 (putative)
UL71 Unknown function (E) UL51 DNA packaging/cleavage (E) +
UL71 Unknown function (E) UL71 Unknown function (E) 2 (putative)
UL71 Unknown function (E) UL89.2 DNA packaging/cleavage (E) +
UL72 Unknown function (D) UL24 Tegument protein (NE) +
UL72 Unknown function (D) UL26 Transcription (D) 2 (putative)
UL72 Unknown function (D) UL94 Tegument Protein (E) 2 (putative)
UL83 Tegument (immunomodulation) (NE) UL25 Tegument protein (NE) +
UL89.2 DNA packaging/cleavage (E) UL89.2 DNA packaging/cleavage (E) 2 (putative)
UL103 Unknown function (D) UL48N Tegument protein (E) 2 (putative)
UL103 Unknown function (D) UL103 Unknown function (D) 2 (putative)
UL112.1 Early protein (D) UL25 Tegument protein (NE) 2 (putative)
UL122 IE-2 (Transcription) (E) UL25 Tegument protein (NE) +
UL122 IE-2 (Transcription) (E) UL122 IE-2 (Transcription) (E) +
US24 Tegument protein (NE) US23 Tegument protein (D) 2 (putative)
Tegument Protein-Envelope Protein Interactions
UL24* Tegument protein (NE) UL77 DNA packaging/cleavage (E) +
UL32 (Tegument) Basic phosphoprotein (E) UL77 DNA packaging/cleavage (E) 2 (putative)
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proteins encoded by vaccinia virus [31] and five herpesviruses
HSV-1, MCMV, KSHV, VZV, and EBV [21,22,23]. Further-
more, the potential interactions among 5 capsid proteins and 28
tegument proteins of HCMV have recently been investigated
using the YTH approach [20]. Although powerful in the amount
of data generated by the many interactome studies, much work
still remains to fully understand the biological significance of the
identified interactions. Nonetheless, the interactome studies have
proven to be very valuable starting points for predicting functions
of unknown proteins when found to interact with known partners.
In addition, they serve as building blocks for many systems-level
studies [37]. In this study, we used the yeast two-hybrid screen
approach to study potential binary interactions among HCMV-
encoded virion proteins. Our YTH analysis revealed 79 potential
interactions, 45 of which were also identified using co-IP
experiments by expressing these proteins in human cells.
It has been reported that two-hybrid screens may generate
significant number of false positives [25]. One type of false
positives may represent random generation of histidine-positive
colonies. This is possibly due to rearrangement and deletion of the
DNA-binding domain plasmids, recombinational events between
the DNA-binding and activation domain plasmids, and genomic
rearrangement of the host strain. Other types of false positives may
be due to either non-specific activation of different reporter
systems or autoactivation, which is caused by activators of
transcription with only the binding domain-fusion proteins.
Similarly, false negatives may arise from the YTH screens. YTH
systems that test for protein interactions in the nucleus are prone to
false negatives due to the expression of proteins that are normally
not found in the nuclear environment. Furthermore, this system
may potentially miss interactions involving proteins with signifi-
cant hydrophobic domains such as membrane proteins, which
may not be folded correctly.
To exclude these possibilities, five different sets of experiments
have been carried out. First, plasmid DNA from the yeast
transformants was recovered and analyzed. Our results indicated
that these constructs were present in all transformants examined
and exhibited similar restriction enzyme profiles as those in E. coli,
suggesting that there is no significant change or rearrangement of
the sequence of the transformants during the screening process.
Second, all screens were carried out in duplicate to determine
whether the results were reproducible. Third, prior to any matings
in our experiments, all of the binding domain-fusion proteins have
been tested for autoactivation and those positive ones were
subsequently removed from this study. Fourth, we have employed
a high stringency selection in the YTH analysis by utilizing 4
different reporters to ensure the validity of the data. We also
observed similar growth of the diploid yeast cells representing the
positive interactions. Any protein that resulted in histidine-positive
growth with the empty vector controls (i.e. pGADT7 and
pGBKT7) was classified as a false positive. Fifth, many of the
identified interactions were further examined by expressing these
proteins in human cells. Whether they associate with each other in
human cells was investigated by co-IP experiments.
To our best knowledge, 58 of these 79 interactions found in our
YTH screens have not been reported previously while 17 have
been found in HCMV and 4 in other herpesviruses (Table 1 and 2)
[15,16,17,20,23,24,36,38,39,40,41]. Furthermore, all the previ-
ously identified 21 interactions and 24 of the new 58 interactions
were positive in co-IP experiments, suggesting the presence of
these interactions in human cells. The identified interactions can
be classified into four different categories based on the locations of
these viral proteins in the virion.
(A) Interactions of viral capsid proteins
Extensive studies have been carried out to investigate the
interactions between capsid proteins [10,11]. Our YTH screens
coupled with co-IP experiments revealed four interactions, all
of which have been previously identified [15,16,17,18,19,
20,42], validating our approach for identifying protein-protein
interactions.
(B) Interactions between viral capsid and tegument
proteins
Both the YTH and co-IP analyses revealed novel potential
interactions of tegument protein UL24 to capsid protein 46 and
BD ORFs and Function AD ORFs and Function Co-IP
UL38 Apoptosis Inhibitor (D) UL24 Tegument protein (NE) 2 (putative)
UL38 Apoptosis Inhibitor (D) UL89.2 DNA packaging/cleavage (E) 2 (putative)
UL43 Tegument protein (NE) UL77 DNA packaging/cleavage (E) 2 (putative)
UL45 Ribonucleotide reductase homologue (NE) UL77 DNA packaging/cleavage (E) 2 (putative)
UL50 Nuclear egress (E) UL48N Tegument protein (E) 2 (putative)
UL50 Nuclear egress (E) UL48C Tegument protein (E) 2 (putative)
UL54 DNA polymerase catalytic subunit (E) UL77 DNA packaging/cleavage (E) 2 (putative)
UL69 Transcription (D) UL77 DNA packaging/cleavage (E) 2 (putative)
UL103 Unknown function (D) UL22A Glycoprotein (D) 2 (putative)
UL132 Glycoprotein (D) UL48N Tegument protein (E) +
Envelope Protein-Envelope Protein Interactions
UL50 Nuclear egress (E) UL77 DNA packaging/cleavage (E) +
UL132 Glycoprotein (D) UL22A Glycoprotein (D) +
Interactions marked by an asterisk represent reciprocal interactions. ‘‘+’’ and ‘‘2’’ represent positive or negative interactions identified by co-IP experiments in human
cells (co-IP). The ORFs in which deletion results in no viral growth, wildtype-like growth, and significant growth defect in foreskin fibroblasts are marked as ‘‘E’’
(essential), ‘‘NE’’ (non-essential), and ‘‘D’’ (defect) [7].
doi:10.1371/journal.pone.0017796.t002
Table 2. Cont.
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believed that tegument proteins specifically interact with capsid
proteins to initiate the formation of the tegument and to form
mature infectious virions. By cryo-EM, an icosahedrally ordered
tegument layer was visualized in HCMV particles when compared
to precursor capsids prior to DNA encapsidation [8,9]. Further-
more, distinct tegument densities were observed to interact with all
of the structural components of the nucleocapsid. Possible
functions of these capsid-proximal organized tegument proteins
may be involved in serving as a nucleus for further tegument
Figure 4. Co-immunoprecipitation (co-IP) of transiently expressed viral proteins. HeLa cells were co-transfected with a combination of two
plasmids expressing HA- and myc-tagged proteins. Panels (A) and (B) are inputs that show the expression of HA- and myc-tagged proteins detected
by Western blot analysis with anti-HA and anti-myc antibodies, respectively. Lanes 1 and 9 are from the same cell lysate, likewise, lanes 2 and 10, and
so on. Lanes 7, 8, 15, and 16 are negative controls based on our YTH data that revealed no interactions. Panels (C) and (D) represent co-IP experiments
(IP-anti-HA) with anti-HA agarose antibodies and visualized by Western blot analysis using anti-HA and anti-myc antibodies, respectively. Panels (E)
and (F) are co-IP experiments (IP-anti-myc) with anti-myc agarose antibodies (IP-anti-Myc) and visualized by Western blot analysis using anti-HA and
anti-myc antibodies, respectively. The protein species, which migrated at approximately 82 kDa and was detected by the anti-HA antibody in the
input protein samples of the cell lysate (A) but not in the protein samples immunoprecipitated with either the anti-HA or anti-myc antibodies (C and
E), may represent a cellular protein that non-specifically reacts with the anti-HA antibody.
doi:10.1371/journal.pone.0017796.g004
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been clearly determined. So far only one interaction between
HCMV tegument proteins and capsid proteins has been reported.
Gibson and coworkers have shown that UL32 can bind to
intranuclear HCMV capsids via its amino-third domain [43].
Previous studies using YTH screens as well as our results here
failed to detect interactions of UL32 with any HCMV capsid
proteins. This may possibly be because the region of the capsid
protein that interacts with UL32 is only folded properly when the
protein is present in the capsid, and therefore, the interactions
between this protein and UL32 can not be detected by YTH
screens as these proteins are expressed in the absence of capsid
formation [43].
Our YTH and co-IP analyses provide the first direct evidence of
potential interactions between tegument protein UL24 and capsid
proteins UL46 and UL85 (Table 2 and Supporting Information
Table S2, Figure 3). The UL24 protein has been detected in the
tegument [12,44]. Gene-deletion analyses indicate that UL24 is
not essential for viral growth in human foreskin fibroblasts but is
important for viral replication in microvascular endothelial cells
[7]. However, its exact function is currently unknown. It is possible
that UL24 may function as a ‘‘hub’’ to connect viral capsids to
other tegument proteins that it interacts with, and facilitate
tegument formation by recruiting other tegument proteins to the
capsid.
(C) Interactions among tegument proteins
It is generally believed that tegument proteins interact with each
other as well as with human proteins to maintain the structure of
the tegument and play an important role in recruiting proteins
during tegument formation. Nineteen specific interactions among
HCMV tegument proteins have been reported and include the
self-interaction of UL25, UL44, UL45, UL69 and UL112, and the
interaction of UL25-UL26, UL32-UL35, UL32-UL82, UL35-
UL82, UL43-UL83, UL45-UL25, UL45-UL69, UL82-UL94,
UL88-UL48, UL99-UL94, UL32-UL45, UL48-UL45, UL69-
UL88, UL94-US22 [20,22,36,39,45].
Of the 79 interactions identified by our YTH analysis, 58
(.73%) are between tegument proteins (Table 1 and 2). Our
results confirm the previously identified 13 interactions (i.e. self-
interaction of UL25, UL69, and UL112; and interaction of UL25-
UL26, UL32-UL35, UL32-UL82, UL35-UL82, UL43-UL83,
UL45-UL25, UL45-UL69, UL82-UL94, UL88-UL48, and
UL99-UL94) (Table 1). Furthermore, these results suggest the
presence of 45 possible interactions between tegument proteins, 21
of which were also positive in co-IP experiments (Table 2). The
salient features of these interactions are as follows:
(1) Both YTH and co-IP experiments identified 7, 9, and 5
interactions that were involved with UL24, UL25, and
UL89.2, respectively. Thus, UL24, UL25, and UL89 may
function as a hub or organizing center for connecting multiple
virion proteins in the mature virion and for recruiting other
virion proteins during virion maturation and assembly.
(2) Previous studies have suggested that proteins of similar
functions may interact with each other to achieve their
function synergistically and co-operatively [21,22,31]. For
example, UL35 and UL82 have been shown to interact with
each other, and form a complex that functions to activate viral
transcription cooperatively and synergistically [45]. Identify-
ing the binding partners of an unknown protein may shed
light into its potential biological function. Excluding those
interactions that are involved in UL24, UL25, and UL89.2,
which may function to recruit tegument proteins, the majority
(24) of the remaining 25 interactions identified in YTH
experiments are either between essential genes or between
genes that are important for viral replication in human
foreskin fibroblasts (Table 1 and 2) [7]. For example, both the
YTH and co-IP analysis identified the interactions of UL71,
an essential protein, with UL51 and UL89, which are essential
for viral DNA genome cleavage and packaging [1,7,46].
These results suggest that UL71 may play its essential role in
supporting viral DNA encapsidation. Further studies will be
carried out to investigate the roles of UL71 and its interactions
with UL51 and UL89 in viral replication.
(D) Interactions between viral tegument proteins and
envelope proteins and among envelope proteins
Little is currently known about the interactions between viral
tegument and envelope proteins. Our YTH analysis suggests 12
potential interactions between tegument proteins and envelope
proteins. In particular, the UL24-UL77 and UL132-UL48
interactions were identified by both the YTH and co-IP analyses.
Furthermore, novel interactions between envelope proteins,
UL22A-UL132 and UL77-UL50, were also identified by both
the YTH and co-IP experiments. Both UL77 and UL50 are
essential for viral replication [7,46]. However, the exact function
of UL77 is currently unknown while UL50, along with a non-
virion protein UL53, functions to dismantle the inner nuclear
membrane and facilitate the budding of the nucleocapsid into the
nuclear membrane during the initial step of acquiring the viral
envelope [47,48]. It will be interesting to investigate whether
UL77 interacts with UL50 and exerts similar function in
supporting the budding of the nucleocapsid through the nuclear
membrane. UL132 encodes a glycoprotein that may play an
important structural function during viral replication in vitro [49].
ORF UL22A, which is also called UL21.5, is believed to encode a
RANTES decoy receptor glycoprotein found in the virion [12,50].
It will be interesting to determine whether UL22A forms a
complex with UL132 to exert their functions in supporting viral
growth during HCMV infection.
We note that our results failed to detect a number of
interactions between HCMV virion proteins that have been
previously identified by YTH analysis, including the seven
interactions (i.e. self-interaction of UL44 and UL45; interaction
of UL32-UL45, UL48-UL45, UL69-UL88, UL94-US22, UL86-
UL46) reported recently [20]. This may be due to the difference in
the yeast strains, activation/DNA binding domain vectors, and the
selection medium/reporters that were used for the studies. Little
overlap of interactions identified by different research groups has
been observed in the YTH studies of other systems including
herpesviruses such as EBV and KSHV [21,22,23,24]. There are
also a number of previously reported interactions between viral
envelope proteins that were not detected in our current study. This
may not be surprising as most of the viral envelope proteins may
not be folded properly in our YTH screen system, and therefore,
may not possess the correct conformations for binding and
interactions. Moreover, YTH systems that test for protein
interactions in the nucleus are prone to false negatives due to
the expression of proteins that are normally not found in the
nuclear environment. These issues can be resolved by using
affinity purification assays to detect interactions in vivo. However,
co-IP experiments can only detect relatively stable, high affinity
interactions while the YTH methods reveal transient, weak
interactions. This is because the dissociation constant (Kd) for a
typical YTH assay is 10–100 mM compared to ,10 mM for co-IP
experiments [51]. Fifty-seven percent of the interactions revealed
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consistent with previous observations that about 50–60% of the
YTH interactions are positive in immunoaffinity pulldown
experiments in the studies of other viruses [21,22,23,24,31]. While
we can not completely rule out the possibility that those
interactions which are negative in co-IP experiments may not be
present in mammalian cells, it is conceivable that these
interactions are so transient and weak that they are only detected
by the YTH approach but not by the immunoaffinity pulldown
assay.
The HCMV virion represents one of the most complex viral
particles found in nature. It contains more than 55 HCMV
proteins of at least 100 amino acids, and in addition, at least 10
viral-encoded small peptides/proteins of less than 100 amino acids
and over 70 human cellular proteins [12,13]. Of the 56 ORFs we
studied, 19 were either not found to interact between themselves
or with any other of the 37 HCMV proteins. We can not
completely exclude the possibility that there were interactions
among themselves or with the other 37 ORFs in human cells that
could not be detected by our YTH assays. It is also conceivable
that these proteins may interact with the viral encoded small
peptides, human proteins, and other constituents of the virion
particles (e.g. lipids). Further studies to identify the partners of
these proteins and study their potential interactions with the
partners will provide insight into the mechanism of HCMV virion
assembly and formation, and facilitate the development of novel
compounds and new strategies for the treatment and prevention of
HCMV infection.
Materials and Methods
Construction of plasmids
HCMV TowneBAC (accession no. AY315197) [7] was used as
the template for PCR amplification of HCMV ORFs . For genes
that encode spliced transcripts, cDNAs from TowneBAC-infected
cells were used as the templates. Table S1 (Supporting
Information) lists the primers used for cloning HCMV sequences
in the pGBKT7 bait and pGADT7 prey plasmids for expression in
yeast and in pCMV-Myc and pCMV-HA for expressing in human
cells (Clontech, Mountain View, CA). Each primer sequence
contains an outer and inner restriction enzyme site for cloning the
HCMV sequences at the multiple cloning site (MCS) of the yeast
and mammalian expression plasmids, respectively (Table S1)
(Supporting Information). PCR amplification was performed using
iProof high-fidelity DNA polymerase (Bio-Rad, Inc., Hercules,
CA). The resultant constructs were confirmed by restriction digest
profile and sequencing.
Yeast two-hybrid (YTH) analysis
The DNAs of the viral ORFs that were cloned into both
pGBKT7 and pGADT7 were transformed into AH109 (MATa)
and Y187 (MATa) yeast strains, respectively (Matchmaker 3
System, Clontech). AH109 strains harboring pGBKT7 plasmids
were maintained in minimal SD media with tryptophan dropout
supplement (SD/-Trp) while Y187 strains harboring pGADT7
plasmids were maintained in minimal SD media with leucine
dropout supplement (SD/-Leu).
Prior to performing matings, individual AH109 strain was
plated on SD/-Ade/-His/-Trp agar with 40 mg/ml X-a-Gal, and
tested for autoactivation. AH109 strains containing the sequences
of seven ORFs (UL48.5, UL26, UL48N, UL48C, UL94, US23,
and UL51) were determined to be autoactivators in the absence of
any pGADT7-cloned ORFs, and subsequently eliminated from
further mating experiments.
Yeast mating was carried out by inoculating fresh colonies (,2
weeks old) of both AH109 and Y187 strains into 1.5 ml
microcentrifuge tubes containing 0.5 ml of YPDA media and
incubated at 30uC with shaking at 200 rpm for 24 hours. There
were a total of 3068 possible combinations (52 AH109659 Y187)
and each mating combination was performed in duplicates. To
select for diploids that have successfully been mated, yeast mating
cultures were centrifuged at 14,000 rpm for 15 seconds, resus-
pended in 0.5 ml Tris-EDTA buffer, and plated in one well of 48-
well plates containing 1 ml of SD/-Leu/-Trp agar and incubated
at 30uC for 3–5 days. Diploid colonies from each successful mating
were then picked from each well, resuspended with TE buffer, and
plated in one well of 48-well plates containing 1 ml of SD/-Ade/-
His/-Leu/-Trp (quadruple drop-out (QDO)) agar with 40 mg/ml
of X-a-Gal.
Three weeks after plating the mated diploid yeasts, the QDO
plates were scored for positive protein-protein interactions. QDO/
X-a-Gal plates represent a high selection stringency for eliminat-
ing possible false positives. AH109 strains contain three reporters-
ADE2, HIS3, and MEL1 (encodes a-galactosidase) under unique
GAL4 upstream activating sequences (UASs) and TATA boxes.
The mating between AH109 transformed with a plasmid
expressing the GAL4 binding domain (BD)-p53 fusion protein
and Y187 transformed with a plasmid expressing the GAL4
activation domain (AD)-T (SV40 T antigen) fusion protein was
used as the positive control. The mating between AH109
transformed with a plasmid expressing the BD-Lamin fusion
protein and Y187 transformed with a plasmid expressing AD-T
was used as the negative control. Growth of the diploid yeast cells
representing the positive interactions was further analyzed.
When scoring the duplicates, if both had no yeast growth after 3
weeks incubation, the fusion proteins were considered non-
interacting partners. When the duplicates both had blue yeast
colonies or if only one of the wells had blue yeast colonies, that
mating combination was repeated until the results from two of
three independent experiments are consistent.
Co-immunoprecipitation (co-IP) analysis
HeLa and U373MG cells, which were obtained from American
Type Culture Collection (ATCC) (Manassas, VA), were co-
transfected with the DNAs of the generated expression constructs
that were derived from pCMV-myc and pCMV-HA and
contained the HCMV ORF sequences, with the aid of
Lipofectamine 2000 (Invitrogen, Carlsbad, CA). In some exper-
iments, U373MG cells expressing a T7 RNA polymerase, which
supported HCMV lytic replication, were co-transfected with the
constructs that were used for the YTH analysis. The expression of
T7 polymerase in these cells induced the expression of the HCMV
ORFs cloned in the pGBKT7 and pGADT7 vectors. Cell lysates
were harvested at 3 days post-transfection. Co-immunoprecipita-
tion experiments were performed using the ProFound Mammalian
HA Tag IP/Co-IP and c-myc Tag IP/Co-IP kits following the
manufacturer’s protocol (Pierce, Rockford, IL).
Western blot analysis
The denatured polypeptides from cell lysates were separated on
SDS-polyacrylamide gels cross-linked with N,N0-methylenebisa-
crylamide, transferred electrically to nitrocellulose membranes
[14,52]. Detection of tagged proteins was performed by incubation
with mouse anti-myc or rabbit anti-HA antibodies (Clontech,
Mountain View, CA) and reacted in an enzyme-linked immuno-
assay with either anti-mouse IgG or anti-rabbit IgG conjugated
with horse radish peroxidase (Vector Laboratories, Burlingame,
CA) [53]. The membranes were subsequently stained with a
HCMV Virion Protein Interactions
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nescent substrate kit.
Supporting Information
Table S1 The primers used to clone the coding sequences of
HCMV ORFs in yeast and mammalian expression vectors. The 59
end of each primer contains two restriction enzyme sites for
cloning into the expression plasmids.
(DOC)
Table S2 Yeast two-hybrid mating results between constructs
that contained DNA sequences coding for 59 binding domain (BD)
and 59 activation domain (AD) fusion proteins. ‘‘AA’’ represents
BD fusion proteins that are identified as autoactivators. ‘‘2’’
represents matings that resulted in no interactions. Highlighted
‘‘P’’ represents positive interactions by YTH mating. There was no
significant difference in the growth of the diploid yeast cells
representing all the positive interactions.
(DOC)
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